At BASF, we create chemistry for a sustainable future. Our ambition: We want to be the preferred chemical company to enable our customers’ green transformation. We combine economic success with environmental protection and social responsibility. Around 108,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world.
Our portfolio comprises, as core businesses, the segments Chemicals, Materials, Industrial Solutions, and Nutrition & Care; our standalone businesses are bundled in the segments Surface Technologies and Agricultural Solutions.
Optimism is what drives all human beings. At BASF, this motivates us every day to develop solutions for the greatest challenges of our time – so we can better protect the climate, make optimal use of limited resources and provide food, energy and clean water for a booming world population.
Our Research Focus: Overcoming the challenges of our time
As a global leader in chemical R&D, BASF develops solutions for a sustainable future. Our research helps secure safe, high-quality food, advances cleaner and safer mobility through battery materials, and supports a circular economy with biobased products and new recycling processes. We also drive climate-smart production by improving energy efficiency, expanding renewable energy use and developing CO2-free technologies such as methane pyrolysis. Across hundreds of projects worldwide, our researchers help customers meet changing needs, regulations and sustainability goals.
BASF generated sales of around €60 billion in 2025. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States.
Credits: https://www.basf.com/global/en/legal/credits
Data protection information: https://www.basf.com/global/en/legal/data-protection-at-basf.html
Eisai’s Corporate Concept is “to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides.” Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.
In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), with working on various activities together with global partners.
nanoComposix has 20+ years of experience helping innovators bring nanotechnology-enabled products to market. We support every stage of the product lifecycle from feasibility to large-scale production through our broad portfolio of high-quality nanoparticles and custom development and manufacturing services.
Our precisely engineered, highly characterized nanoparticles power advances in applications such as diagnostics, drug delivery, and optical technologies, helping customers improve assay performance, enhance therapeutic outcomes, and solve complex material challenges. Whether you need reliable off the shelf materials or a partner to develop and scale a breakthrough idea, nanoComposix supports you from concept to commercialization.